News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KIKA Clinical Solutions Achieves ISO Certification Renewal for U.S. and French Operations


2/1/2010 11:27:51 AM

BOSTON, MA and PARIS--(Marketwire - February 01, 2010) - KIKA™ Clinical Solutions announced the successful completion of its ISO renewal audit for its operations in the U.S. and France. KIKA is the leading provider of advanced EDC solutions for Clinical Asset Management™ for the pharmaceutical, biotechnology and medical device markets.

KIKA renewed for the updated ISO standard ISO 9001 version 2008. The certification body was SGS, the world's largest control and inspection company.

ISO recertification requires an annual follow-up audit and a more thorough renewal audit every three years. Renewal is not automatic. For this audit KIKA had a new ISO auditor, which offered a fresh eye to ensure that KIKA's QMS compliance was entirely consistent.

KIKA CEO Linda Beneze commented, "It's especially important for customers and partners that our ISO renewal audit covered all of KIKA's operations and processes worldwide. It guarantees global uniform processes for sponsors conducting multi-country clinical trials with our Veracity™ advanced EDC solution."

About KIKA Clinical Solutions

KIKA helps the world's most innovative biopharmaceutical and medical device organizations use advanced EDC solutions to bring much-needed medical solutions to market faster. KIKA's Veracity™ is the leading-edge Web-based clinical trial software platform that delivers Clinical Asset Management™ for any size clinical trial. Veracity is customized to meet study needs precisely. It provides unmatched flexibility and customization with advanced EDC including images and online adjudication. Veracity is backed by the industry's most reliable IT infrastructure and a world class Professional Services organization. For more information, visit www.kikaclinicalsolutions.com.

KIKA, Veracity and Clinical Asset Management are trademarks of the KIKA group of companies.

Visit KIKA Clinical Solutions on Facebook and on Twitter as KIKAClinical.


Media contact:
Brenda Nashawaty
Email Contact
617-688-3253


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES